October 16, 2020
Bulletin interne de l'Institut Pasteur
Languages
BIP : The Institut Pasteur Newsletter, October 16, 2020
Innate immunity is the fastest-acting component of the immune system, but so far little is known about its role during infection with SARS-CoV-2. A few hours after an infection, the body emits an alarm signal, interferon, enabling cells that have not yet been infected to produce antiviral proteins. This phenomenon occurs well before the production of neutralizing antibodies.
A further step has just been taken in understanding the mechanisms that allow some individuals to control HIV infection without treatment. A research team led by Dr. Asier Sáez-Cirión (Institut Pasteur) and Dr. Bruno Vaslin (IDMIT, CEA-Inserm-Université Paris Saclay) observed for the first time that the antiviral activity of CD8+ T cells of "controller" macaques infected with the simian immunodeficiency virus (equivalent to HIV for non-human primates) was initially limited in the first two weeks of infection, but increased thereafter.
From October 7 to 11, during this year's Pasteurdon campaign, the Institut Pasteur once again flew the flag for research and for those who best embody it – the scientists who lead the battle day in, day out.
The Scientific Secretariat General compiles information on the week’s conferences and publications, patents, funding opportunities, job vacancies, training and events that you may find useful for your career...
From January 1, 2021, the company Verspieren will become the new manager of the Institut Pasteur's provident insurance/healthcare contract, taking over from the company Vivinter. This new partner was chosen to optimize the management of the contract for Institut Pasteur staff and to improve the quality of the platform.
